Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Abnormal control of orbicularis oculi reflex excitability in multiple sclerosis.
Development of systemic sarcoidosis and xanthoma planum during multiple sclerosis treatment with interferon-beta 1a: Case Report.
Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: An in vivo [(11)C](R)-PK11195-PET pilot study.
Multiple sclerosis: from molecules to treatment.
Walking capacity and ability are more impaired in progressive compared to relapsing type of multiple sclerosis.
Killer-Cell Immunoglobulin-Like Receptor Expression on Lymphocyte Subsets in Multiple Sclerosis Patients Treated with Interferon-β: Evaluation as Biomarkers for Clinical Response.
Neuroprotective effects of chrysin: From chemistry to medicine.
Mesenchymal stem cell transplantation in multiple sclerosis.
Sleep loss as risk factor for neurologic disorders: A review.
Evaluation of retinal nerve fiber layer thickness measured by optical coherence tomography in Moroccan patients with multiple sclerosis.
Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program.
ADEM Following Malaria.
Application of laser radiation and magnetostimulation in therapy of patients with multiple sclerosis.
Ten-year follow-up of the 'minimal MRI lesion' subgroup from the original CHAMPS Multiple Sclerosis Prevention Trial.
Information provision for people with multiple sclerosis.
Environmental factors in multiple sclerosis.
Multiple sclerosis: KIR4.1 as an autoantigen in MS-new questions raised.
Efficient in vivo depletion of CD8(+) T lymphocytes in common marmosets by novel CD8 monoclonal antibody administration.
Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.
Vitamin D and multiple sclerosis.
Prevalence and predictors of depression in Iranian patients with multiple sclerosis: a population-based study.
Vitamin D in Systemic and Organ-Specific Autoimmune Diseases.
Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica.
Targeting calpain-mediated proteolysis and peptide signaling as a strategy to reduce injury in multiple sclerosis.
The primary vascular dysregulation syndrome: implications for eye diseases.

Pages